Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

Our priorities paint a picture of who we are, and that’s as true in RNAi medicine development as it is elsewhere in life

An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease

How a streamlined CLD process can fast-track biologics to IND

How a complex but common carbohydrate could help add a new dimension to 3D-printed pills

New technologies offer cheaper modes of manufacture – here’s how and why the world’s less wealthy countries could seize the moment.

UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Leaders at Artios explore the potential of expanding therapeutic opportunities in DDR beyond synthetic lethality